z-logo
Premium
Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence
Author(s) -
Han Ying-Hao,
Kim Hyun-Sun,
Kim Jin-Man,
Kim Sang-Keun,
Yu Dae-Yeul,
Moon Eun-Yi
Publication year - 2005
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2005.07.049
Subject(s) - senescence , peroxiredoxin , reactive oxygen species , kinase , mapk/erk pathway , p38 mitogen activated protein kinases , microbiology and biotechnology , chemistry , oxidative stress , fibroblast , extracellular , biology , enzyme , biochemistry , in vitro , peroxidase
Reactive oxygen species (ROS) were generated in all oxygen‐utilizing organisms. Peroxiredoxin II (Prx II) as one of antioxidant enzymes may play a protective role against the oxidative damage caused by ROS. In order to define the role of Prx II in organismal aging, we evaluated cellular senescence in Prx II −/− mouse embryonic fibroblast (MEF). As compared to wild type MEF, cellular senescence was accelerated in Prx II −/− MEF. Senescence‐associated (SA)‐β‐galactosidase (Gal)‐positive cell formation was about 30% higher in Prx II −/− MEF. N ‐Acetyl‐ l ‐cysteine (NAC) treatment attenuated SA‐β‐Gal‐positive cell formation. Prx II −/− MEF exhibited the higher G2/M (41%) and lower S (1.6%) phase cells as compared to 24% and 7.4% in wild type MEF, respectively. A high increase in the p16 and a slight increase in the p21 and p53 levels were detected in PrxII −/− MEF cells. The cellular senescence of Prx II −/− MEF was correlated with the organismal aging of Prx II −/− mouse skin. While extracellular signal‐regulated kinase (ERK) and p38 activation was detected in Prx II −/− MEF, ERK and c‐Jun N‐terminal kinase (JNK) activation was detected in Prx II −/− skin. These results suggest that Prx II may function as an enzymatic antioxidant to prevent cellular senescence and skin aging.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here